InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,222.68
(
0.16%
)
US TECH 100
17,650.00
(
0.05%
)
Dow Jones
39,512.84
(
0.32%
)
Brent Oil
82.59
(
0.00%
)
Bitcoin
61,037.51
(
0.40%
)
Post# of 216
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Keep Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

TREND1

Send PM Follow Ignore
Followers 417
Posts 52354
Boards Moderated 13
Alias Born 12/16/2001

TREND1

Member Level

Re: None

Thursday, 09/01/2016 11:28:53 AM

Thursday, September 01, 2016 11:28:53 AM

Post# of 216
*****Don't Buy The MannKind EpiPen Hype

Sep. 1, 2016 9:30 AM ET

Summary


•MNKD is the carcass of a failed venture with a share structure constantly being blown out and no future cash flush profit generation prospects on the horizon.

•It was recently announced they could be looking at producing a generic version of EpiPen via an inhaler, an idea we can only see as a total disaster.

•We're not buying the hype and we're certainly not buying MNKD




http://seekingalpha.com/article/4003562-buy-mannkind-epipen-hype?auth_param=1vat:1bsgbca:dc7a0eb2d088cf9cfc80abe63e9ff94c&uprof=51

MAIN BOARD http://investorshub.advfn.com/TRADING-3X-ETFs-TNA-NUGT-ETC-12981/

Public Reply Private Reply New Post
Keep Last Read
Keep Last Read Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up